Evidence map›Paper›PMID 22109558›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2011

T-cell factor 1 is a gatekeeper for T-cell specification in response to Notch signaling.

Kristine Germar, Marei Dose, Tassos Konstantinou, Jiangwen Zhang, Hongfang Wang, Camille Lobry, Kelly L Arnett, Stephen C Blacklow, Iannis Aifantis, Jon C Aster and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 133 papers.

0numbers the graph read from it
0cells of the map it votes in
133citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

133 citing papers in PubMed, 213 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. T Cell Development: From T-Lineage Specification to Intrathymic Maturation.Advances in experimental medicine and biology · 2025
    Review
  11. Article
  12. Article
  13. Transcriptional network dynamics in early T cell development.The Journal of experimental medicine · 2024
    Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. T cells in health and disease.Signal transduction and targeted therapy · 2023
    Review

73 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Kristine GermarKnapp Center for Lupus and Immunology Research, University of Chicago, Chicago, IL 60637, USA.
Marei Dose
Tassos Konstantinou
Jiangwen Zhang
Hongfang Wang
Camille Lobry
Kelly L Arnett
Stephen C Blacklow
Iannis Aifantis
Jon C Aster
Fotini Gounari
Harvard University · USUniversity of Chicago · USBrigham and Women's Hospital · USHoward Hughes Medical Institute · USNew York University · USTufts University · US

Funding

Structure and Function in Notch SignalingR01CA092433 · NCI · HARVARD MEDICAL SCHOOL · PI BLACKLOW, STEPHEN C. · 2002 to 2016
$5.0M
The role of the SCF/FBW7 ubiquitin ligase complex in hematopiesis and leukemia.R01CA133379 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI AIFANTIS, IANNIS · 2009 to 2018
$3.6M
Regulation of hematopoietic stem cell differentiationR01CA105129 · NCI · UNIVERSITY OF CHICAGO · PI AIFANTIS, IANNIS · 2005 to 2014
$2.8M
Mechanisms of T cell leukemia induction and maintenanceR01CA149655 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI AIFANTIS, IANNIS · 2010 to 2015
$2.0M
Signaling in the DN to DP thymocyte transitionR01AI059676 · NIAID · UNIVERSITY OF CHICAGO · PI GOUNARI, FOTINI · 2004 to 2008
$1.8M
Modifiers of Notch stability and their role in cancerR21CA141399 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI AIFANTIS, IANNIS, HUBBARD, E. JANE ALBERT · 2010 to 2011
$399k
Howard Hughes Medical InstituteNCI NIH HHS R01 CA092433NCI NIH HHS R01 CA105129NCI NIH HHS R01CA105129NCI NIH HHS R01 CA133379NCI NIH HHS R01CA133379NCI NIH HHS R01 CA149655NCI NIH HHS R01CA149655NCI NIH HHS R21 CA141399NCI NIH HHS R21CA141399NIAID NIH HHS F31 AI830542NIAID NIH HHS R01 AI059676NIAID NIH HHS R01AI059676
6 · The paper itself

Abstract

Although transcriptional programs associated with T-cell specification and commitment have been described, the functional hierarchy and the roles of key regulators in structuring/orchestrating these programs remain unclear. Activation of Notch signaling in uncommitted precursors by the thymic stroma initiates the T-cell differentiation program. One regulator first induced in these precursors is the DNA-binding protein T-cell factor 1 (Tcf-1), a T-cell-specific mediator of Wnt signaling. However, the specific contribution of Tcf-1 to early T-cell development and the signals inducing it in these cells remain unclear. Here we assign functional significance to Tcf-1 as a gatekeeper of T-cell fate and show that Tcf-1 is directly activated by Notch signals. Tcf-1 is required at the earliest phase of T-cell determination for progression beyond the early thymic progenitor stage. The global expression profile of Tcf-1-deficient progenitors indicates that basic processes of DNA metabolism are down-regulated in its absence, and the blocked T-cell progenitors become abortive and die by apoptosis. Our data thus add an important functional relationship to the roadmap of T-cell development.

Indexed as

AnimalsBone Marrow CellsCell LineageCell MovementMiceMice, Inbred C57BLProto-Oncogene Proteins c-kitReceptors, NotchSignal TransductionStem CellsT Cell Transcription Factor 1ThymocytesT-LymphocytesProto-Oncogene Proteins c-kitReceptors, NotchT Cell Transcription Factor 1

Identifiers

PMID22109558
PMCPMC3250146
OpenAlexW2104114315

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.